ImsHealth posts
FeedPosted Oct 22nd 2007 10:33AM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Analyst upgrades and downgrades, Walgreen Co (WAG), Sprint Nextel Corp (S), Altria Group (MO), Xerox Corp (XRX)
.gif)
MOST NOTEWORTHY: Clearwire, Citrix Systems, Altria Group, Overstock.com and Interpublic Group were today's noteworthy upgrades:
- Jefferies upgraded shares of Clearwire Corporation (NASDAQ: CLWR) to Buy from Hold on valuation as they believe the stock is trading as if the Sprint Nextel Corporation (NYSE: S) deal is off. Jefferies thinks the Sprint/Clearwire deal is still in the best interest of both companies.
- Deutsche Bank upgraded shares of Citrix Systems (NASDAQ: CTXS) to Buy from Hold, as they believe the contribution from XenSource beginning in Q4 could be better than expected.
- UBS upgraded shares of Altria Group (NYSE: MO) citing stronger Q3 International results and potential share repurchases. Shares were upgraded to Buy from Neutral.
- Piper Jaffray raised shares of Overstock.com (NASDAQ: OSTK) to Market Perform from Underperform, as they are incrementally more positive on shares following the company's Q3 upside. They believe the company has turned the corner on profitability.
- Bear Stearns upgraded shares of Interpublic Group (NYSE: IPG) to Outperform from Peer Perform on valuation and expectations for improved performance in 2008.
OTHER UPGRADES:
Posted Oct 18th 2007 11:10AM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Analyst upgrades and downgrades, eBay (EBAY),
MOST NOTEWORTHY: Occam Networks, Washington Mutual, Downey Financial and IMS Health were today's noteworthy downgrades:
- Merriman downgraded shares of Occam Networks (NASDAQ: OCNW) to Neutral from Buy as they believe the company's restatement filing raised more questions than it answered and that the company's takeout value is shrinking.
- Friedman Billings downgraded Washington Mutual (NYSE: WM) and Downey Financial Corporation (NYSE: DSL) to Underperform from Market Perform based on credit trends that are eroding faster than anticipated in the housing market.
- William Blair downgraded IMS Health (NYSE: RX) to Market Perform from Outperform following the lower than expected Q3 results to reflect deterioration in the company's market environment. Shares were also downgraded to Sell from Neutral at Goldman Sachs.
OTHER DOWNGRADES:
Comfort Zone Investing: The unmighty dollar
Five winners of a weak dollar
For a quick-read on the U.S. economy, check the price of gasoline
